Radius Health (RDUS) Appoints Jennifer A. Jarrett and Susan Vissers Lisa to its Board

May 20, 2022 9:01 AM EDT

Get instant alerts when news breaks on your stocks. Claim your 1-week free trial to StreetInsider Premium here.

Radius Health, Inc. (Nasdaq: RDUS) today announced that it has added two new independent members to the Board of Directors (the “Board”). Effective immediately, Jennifer A. Jarrett and Susan Vissers Lisa have joined the Board as Class I and Class III directors, respectively. In addition, Radius’ Board also announced several corporate governance changes to further enhance shareholder input.

“I am pleased to welcome both Jennifer and Susie to the Radius Board. Their deep healthcare acumen and extensive operating experience will be invaluable as Radius looks to advance its business on behalf of patients, stakeholders and employees,” said Owen Hughes, Chairman of the Board of Directors. “Their appointments to our Board, as well as the governance enhancements we are announcing today, build on the changes we’ve made over the past 24 months to further align our interests with those of our shareholders.”

The appointments of Ms. Jarrett and Ms. Lisa further expand the Board’s gender diversity and relevant industry expertise, including senior-level experience at large public companies in the life sciences sector. Of the expanded Board’s 10 directors, nine are independent. Six of the Company’s current directors, including Ms. Jarrett and Ms. Lisa, have joined the Board in the past two years, reflecting a deliberate refreshment process across the Company’s leadership.

Board Appointments

  • Jennifer A. Jarrett, 51, is currently Chief Operating Officer and serves on the Board of Arcus Biosciences, a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer. She currently serves on the Board of Syndax Pharmaceuticals, a clinical stage biopharmaceutical company developing cancer therapies. She also serves on the Board of SMART, a non-profit organization whose mission is to help “first generation American” students access and assimilate into private schools in the Bay Area. She previously served as Vice President, Corporate Development and Capital Markets at Uber and on the boards of Arena Pharmaceuticals and Audentes Therapeutics. Earlier in her career she served in senior roles at Medivation, Citigroup Inc. and Credit Suisse Group AG. Ms. Jarrett earned a BA degree in Economics from Dartmouth College and an MBA from Stanford University Graduate School of Business.
  • Susan Vissers Lisa, 53, recently served as Senior Vice President, Investor Relations of CVS Health Corporation through April 2022. Prior to this position, Ms. Lisa was Vice President, Investor Relations at Boston Scientific Corporation for over seven years. Previously, she served as Senior Director, Investor Relations and Corporate Development at Abiomed and held senior roles at BofA Securities, Inc. Ms. Lisa began her career at JPMorgan Chase and Cowen Inc. Ms. Lisa earned a BA degree in Economics and Political Science from Duke University and an MBA from New York University Stern School of Business. She is a CFA charter holder.

Corporate Governance Enhancements

In line with corporate governance best practices, the Company’s Board has proposed reducing the vote required to amend the charter and bylaws from a supermajority to a majority of the shares outstanding, subject to approval by Radius’ shareholders at this year’s upcoming Annual Meeting. In addition, the Board has adopted a “proxy access” provision to allow long-term shareholders to nominate directors in the Company’s proxy statement.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Board Changes, Corporate News

Related Entities

Credit Suisse, JPMorgan, Citi, Stanford, Cowen & Co, FDA